Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-31 11:13 am Purchase | 2024-12-31 | 13D | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 1,051,183 (+75.96%) | Filing History |
| 2024-12-16 09:50 am Purchase | 2024-12-13 | 13D | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 7,216,312 8.500% | 1,614,233 (+28.81%) | Filing History |
| 2024-12-12 12:29 pm Purchase | 2024-12-06 | 13G | PMV Pharmaceuticals, Inc. PMVP | BML Investment Partners, L.P. | 3,269,907 6.300% | 3,269,907 (New Position) | Filing History |
| 2024-11-07 1:15 pm Purchase | 2024-11-01 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 248,445 6.500% | 248,445 (New Position) | Filing History |
| 2024-11-07 12:50 pm Purchase | 2024-11-01 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 4,183,223 (New Position) | Filing History |
| 2024-10-09 11:40 am Purchase | 2024-10-09 | 13G | OnKure Therapeutics, Inc. OKUR | BML Investment Partners, L.P. | 447,815 3.500% | 447,815 (New Position) | Filing History |
| 2024-09-25 7:14 pm Purchase | 2024-09-19 | 13G | Achilles Therapeutics plc ACHL | BML Investment Partners, L.P. | 4,100,002 9.970% | 4,100,002 (New Position) | Filing History |
| 2024-09-16 4:42 pm Purchase | 2024-09-10 | 13G | Oramed Pharmaceuticals Inc. ORMP | BML Investment Partners, L.P. | 2,048,634 5.000% | 2,048,634 (New Position) | Filing History |
| 2024-08-28 4:42 pm Purchase | 2024-08-28 | 13G | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 1,383,817 5.600% | 1,383,817 (New Position) | Filing History |
| 2024-08-14 9:23 pm Purchase | 2024-08-14 | 13G | Talis Biomedical Corporation TLIS | BML Investment Partners, L.P. | 203,569 11.200% | 69,484 (+51.82%) | Filing History |
| 2024-08-14 9:00 pm Purchase | 2024-08-14 | 13G | AN2 Therapeutics, Inc. ANTX | BML Investment Partners, L.P. | 5,749,432 19.300% | 1,500,000 (+35.30%) | Filing History |
| 2024-08-14 8:44 pm Purchase | 2024-08-07 | 13G | Talis Biomedical Corporation TLIS | BML Investment Partners, L.P. | 134,085 7.400% | 134,085 (New Position) | Filing History |
| 2024-08-12 4:48 pm Purchase | 2024-08-09 | 13G | AN2 Therapeutics, Inc. ANTX | BML Investment Partners, L.P. | 4,249,432 14.200% | 4,249,432 (New Position) | Filing History |
| 2024-07-22 4:24 pm Purchase | 2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | Filing History |
| 2024-05-21 10:12 am Purchase | 2024-05-21 | 13G | Reneo Pharmaceuticals, Inc. RPHM | BML Investment Partners, L.P. | 369,296 11.000% | 199,873 (+117.97%) | Filing History |
| 2024-05-21 10:01 am Purchase | 2024-05-13 | 13G | AVROBIO, Inc. AVRO | BML Investment Partners, L.P. | 430,689 11.500% | 63,886 (+17.42%) | Filing History |
| 2024-04-29 4:10 pm Purchase | 2024-04-18 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 1,141,000 5.500% | 655,575 (+135.05%) | Filing History |
| 2024-04-02 4:36 pm Purchase | 2024-03-22 | 13G | Instil Bio, Inc. TIL | BML Investment Partners, L.P. | 346,190 5.300% | 346,190 (New Position) | Filing History |
| 2024-03-19 4:29 pm Purchase | 2024-03-18 | 13G | CYTEIR THERAPEUTICS INC CYTT | BML Investment Partners, L.P. | 3,818,464 10.600% | 348,456 (+10.04%) | Filing History |
| 2024-02-08 11:14 am Purchase | 2024-02-07 | 13G | Aclaris Therapeutics, Inc. ACRS | BML Investment Partners, L.P. | 9,395,934 13.300% | 4,895,934 (+108.80%) | Filing History |